Differences in Bladder Cancer Diagnosis by Demographic Factors: A Simulation Modeling Analysis

PurposeBladder cancer is associated with significant morbidity and mortality in the US, with 85,000 new cases and 17,400 deaths expected in 2025. Black patients are more likely than White patients to be diagnosed with bladder cancer at advanced stages, as are female patients compared with male patients. We examine whether differences in cancer diagnosis rates by race and sex can explain the observed variability using a simulation model and project outcomes of potential improvement in diagnosis. MethodsWe developed a state transition model for bladder cancer to simulate four cohorts based on sex (males, females) and race (Blacks, Whites) from birth through various health states, including disease-free, preclinical stages (0a/0is - IV), clinical stages (0a/0is - IV), and death (bladder cancer or other cause death). Parameters related to disease onset, progression, and diagnosis were estimated by calibrating the model to race- and sex-specific incidence rates by age, and stage distribution at diagnosis for cases diagnosed between 2015 and 2019 in SEER 17 registry areas. We conducted a scenario analysis to examine the impact of differences in diagnosis rates on stage distribution and life expectancy, assuming that Black males (or females) and White females had diagnosis rates similar to those of White males. ResultsThe calibrated model attributes the differences in stage distribution to lower diagnosis rates in White females (hazard ratio, [HR] = 0.95, 95% credible interval [CI]: 0.92 - 0.96), Black males (0.80, 95% CI: 0.75 - 0.81) and Black females (0.56, 95% CI: 0.53 - 0.58), relative to White males. If diagnosis rates for all demographic groups were similar to White males, the expected life span of a 65-year-old bladder cancer patient would increase by 0.2 years for White females (from 13.8 to 13.9 years), 0.6 years for Black males (from 10.6 to 11.1 years), and 1.9 years for Black females (from 10.5 to 12.4 years). ConclusionsDifferences in diagnosis rates of bladder cancer by race and sex explain the observed differences in stage distribution at diagnosis. Targeted interventions aimed at improving diagnosis rates have the potential to substantially improve survival for patients with bladder cancer.